Glenmark gets USFDA nod to market generic drug

Glenmark Pharmaceuticals announced that it has received USFDA approval to market its generic Esomeprazole Magnesium delayed-release capsules, used to treat excess stomach acid conditions. This generic version of Haleon US Holdings LLC's Nexium is expected to compete in a market where Nexium24 HR 20 mg capsules have annual sales of approximately $259.2 million

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0WOFqe7
via IFTTT